1. Home
  2. ENGN vs MTLS Comparison

ENGN vs MTLS Comparison

Compare ENGN & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENGN
  • MTLS
  • Stock Information
  • Founded
  • ENGN 1999
  • MTLS 1990
  • Country
  • ENGN Canada
  • MTLS Belgium
  • Employees
  • ENGN N/A
  • MTLS N/A
  • Industry
  • ENGN
  • MTLS Computer Software: Prepackaged Software
  • Sector
  • ENGN
  • MTLS Technology
  • Exchange
  • ENGN Nasdaq
  • MTLS Nasdaq
  • Market Cap
  • ENGN 349.1M
  • MTLS 349.7M
  • IPO Year
  • ENGN N/A
  • MTLS 2014
  • Fundamental
  • Price
  • ENGN $7.06
  • MTLS $6.18
  • Analyst Decision
  • ENGN Buy
  • MTLS
  • Analyst Count
  • ENGN 7
  • MTLS 0
  • Target Price
  • ENGN $20.29
  • MTLS N/A
  • AVG Volume (30 Days)
  • ENGN 262.1K
  • MTLS 146.7K
  • Earning Date
  • ENGN 09-11-2025
  • MTLS 10-23-2025
  • Dividend Yield
  • ENGN N/A
  • MTLS N/A
  • EPS Growth
  • ENGN N/A
  • MTLS N/A
  • EPS
  • ENGN N/A
  • MTLS 0.11
  • Revenue
  • ENGN N/A
  • MTLS $311,850,851.00
  • Revenue This Year
  • ENGN N/A
  • MTLS $2.98
  • Revenue Next Year
  • ENGN N/A
  • MTLS $7.09
  • P/E Ratio
  • ENGN N/A
  • MTLS $60.22
  • Revenue Growth
  • ENGN N/A
  • MTLS 2.98
  • 52 Week Low
  • ENGN $2.65
  • MTLS $3.93
  • 52 Week High
  • ENGN $11.00
  • MTLS $9.69
  • Technical
  • Relative Strength Index (RSI)
  • ENGN 59.88
  • MTLS 64.29
  • Support Level
  • ENGN $6.07
  • MTLS $5.35
  • Resistance Level
  • ENGN $8.35
  • MTLS $6.41
  • Average True Range (ATR)
  • ENGN 0.64
  • MTLS 0.32
  • MACD
  • ENGN -0.00
  • MTLS 0.09
  • Stochastic Oscillator
  • ENGN 45.18
  • MTLS 80.59

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Share on Social Networks: